Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter?

Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections, including pneumonia. There is concern regarding the emergence of vancomycin tolerance, caused by heterogeneous vancomycin-intermediate S. aureus (hVISA), and subsequent vancomycin treatment f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Claeys, Kimberly C., Lagnf, Abdalhamid M., Hallesy, Jessica A., Compton, Matthew T., Gravelin, Alison L., Davis, Susan L., Rybak, Michael J.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2016
Sujets:
Clinical Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4775950/
https://ncbi.nlm.nih.gov/pubmed/26729497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02388-15
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires